CG Oncology (CGON) Shares Outstanding (Diluted) (2023 - 2026)

CG Oncology (CGON) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 CG Oncology 6.63 Bn 6.63 Bn -2.77 Mn 88.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 88.20 Mn
Mar 31, 2026 84.52 Mn
Dec 31, 2025 77.30 Mn
Sep 30, 2025 76.73 Mn
Jun 30, 2025 76.23 Mn
Mar 31, 2025 76.19 Mn
Dec 31, 2024 62.50 Mn
Sep 30, 2024 67.14 Mn
Jun 30, 2024 66.65 Mn
Mar 31, 2024 47.06 Mn
Dec 31, 2023 4.33 Mn
Sep 30, 2023 4.38 Mn
Jun 30, 2023 3.92 Mn
Mar 31, 2023 3.86 Mn